Table 5
Prognostic factors for RIC transplantation
Outcome
.
Progressive disease
.
Alemtuzumab
.
T-cell depletion
*
.
HR
.
P
.
HR
.
P
.
HR
.
P
.
Survival
2.0
< .001
1.8
.005
ns
ns
PFS
1.9
< .001
1.8
.001
ns
ns
Relapse
1.9
.02
2.3
.001
1.6
.03
NRM
1.9
.01
ns
ns
ns
ns
Outcome
.
Progressive disease
.
Alemtuzumab
.
T-cell depletion
*
.
HR
.
P
.
HR
.
P
.
HR
.
P
.
Survival
2.0
< .001
1.8
.005
ns
ns
PFS
1.9
< .001
1.8
.001
ns
ns
Relapse
1.9
.02
2.3
.001
1.6
.03
NRM
1.9
.01
ns
ns
ns
ns
*
Excluding alemtuzumab.
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal